A new space designed to promote student entrepreneurship is open near Johns Hopkins University’s Homewood campus as the school welcomes students back to campus this week.
A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American disease that can cause long-term neurological problems and even death.
Orthopedics company Stryker announced Thursday that it is buying K2M Group Holdings, a maker of 3-D printed implantable, minimally invasive spine products, for $1.4 billion. Analysts reacted positively pointing out that while a small player K2M will help to boost Stryker’s spine division that has not been performing well as of late.
When: Thursday, September 6, 2018 from 4:30 PM to 7:30 PM EDT
Where: Columbus Center – Baltimore 701 E Pratt St Baltimore, MD 21202
Join us for this exclusive CEO Talks panel event on September 6th in Baltimore!
The second installment of the #CEOTalks event series will bring you insights from local company executives on the game changing technologies they are bringing to market to address one of the greatest public health threats of our age; Anti-microbial Resistance (AMR).
Bringing new treatments to market in this field is made harder by a unique set of market conditions and investment hurdles that executives need to navigate to be successful.
The Institute for Bioscience and Biotechnology Research (IBBR) has entered into two separate collaborations involving its polyphosphazene (PPZ) polymer platform. PPZs are synthetic, biofunctional macromolecules with the potential to advance a wide range of biomedical capabilities. IBBR Fellow, Dr. Alexander Andrianov, is working with collaborators to develop new PPZs for use as coatings for medical devices and as carriers of medical imaging agents.
For entrepreneurs and small business owners, innovation is essential. It differentiates them from their similar-sized competitors, and it’s what allows them to compete with much larger organizations and still thrive.
In just a week’s time, Life Science Nation will be bringing the Redefining Early Stage Investments (RESI) Conference back to the Marriott Copley Place in downtown Boston. Over 700 attendees from the early stage life science world will be at RESI, including startups at the earliest stages of development representing tech hubs from all around the US Northeast in the new RESI Innovator’s Gathering, plus over 300 investors. You can read the program guide below to plan out your day at RESI and see who else will be there. We look forward to seeing you next week.
When: Thursday, September 13, 2018 from 5:00 PM to 7:30 PM EDT
Where: Bar Louie 150 Gibbs St Rockville, MD 20850
Please join us next month at BioBuzz and meet this year’s ‘Buzz of BIO’ winner and Annual BioBuzz Sponsor, Immunomic Therapeutics (ITI), at Bar Louie in Rockville on September 13th.
Get to know the team behind the company that is receivivng such widespread industry attention for the recent evolution of their innovative technology platform, UNITE, which has the potential to alter how we use immunotherapy for cancer, allergies and animal health.
At each stage of growth for a life sciences firm, the funding needs change. Learn about the different types of capital investors and which ones might work best for your firm as a funding source.
emocha Mobile Health, a Baltimore-based company whose video-based technology helps people take their medications as directed, has been awarded a Small Business Innovation Research (SBIR) award from the National Institute On Minority Health And Health Disparities (NIMHD) of the National Institutes of Health (NIH). The award gives emocha an additional $1 million over two years to evaluate its medication adherence platform for patients with tuberculosis (TB) in several sites throughout the United States. Researchers at the Johns Hopkins University School of Medicine will conduct the evaluation.